Drugmaker losing it over med spa weight loss offerings
Reprints
Medical spas, wellness centers and even compounding pharmacies have been marketing their version of a popular weight-loss wonder drug “Mounjaro,” which is sold by pharmaceutical company Eli Lilly and available only by prescription.
Eli Lilly, which filed several lawsuits against several businesses in several states, wants to stop such companies from “the unlawful marketing and sale of non-FDA approved compounded products” which the company says are “fraudulently claiming” to be their name-brand version of a drug containing tirzepatide, CNN reported.
Popular in Hollywood circles and in advertisements on social media, the drug is in the family of diabetes medications – Ozempic and semaglutide among them — now notoriously being used off-label for weight loss.“Lilly filed this lawsuit to protect patients,” the company said in a statement to CNN. “Lilly cannot validate the safety or effectiveness of products claiming to contain tirzepatide that are not our own branded product.”
